Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis
The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Abstract
In summary, available data demonstrate that IL-1 and TNF are the causative agents underlying the bone loss induced by estrogen deficiency. Indeed, these factors are produced in bone and the bone marrow, released in larger amounts from cells of estrogen-deficient subjects, and indispensable for reproducing the effects of estrogen deficiency in bone. These observations support the hypothesis that the bone sparing effect of estrogen is due to the ability of the hormone to block osteoclastogenesis, the activation of mature osteoclasts and, as recently demonstrated, the rate of apoptotic osteoclast death. Although IL-1 and TNF play a prominent causal role in these events, the bone-sparing effect of estrogen is mediated by numerous cytokines which, by simultaneously stimulating multiple target cells, induce effects that are not accounted for by any one single factor (Fig. 2). The ability of estrogen to regulate some, but not all, the cytokines involved in this process is not inconsistent with this hypothesis because cytokines have potent synergistic effects. Thus, a considerable increase in bone resorption may result from a relatively small increase in the concentration of only a few of the bone-resorbing factors present in the bone microenvironment. This concept is best illustrated by the study of Miyaura et al. demonstrating that the concentrations of either IL-1, IL-6, IL-6 receptor, or prostaglandins detected in the bone marrow of OVX mice are insufficient to account for the increased bone resorption caused by estrogen withdrawal. In contrast, the increase in bone resorption induced by OVX can be explained by the cumulative effects of these cytokines. Thus, a better understanding of the cooperative effects of cytokines and a recognition that the contribution of individual cytokines to postmenopausal bone loss varies with the passage of time after menopause are necessary to fully understand the mechanism of action of estrogen in bone. Although the relevance of individual bone-targeting cytokines in species specific, the development of transgenic mice with activatable or deactivatable promoters is likely to result in a further clarification of the integrated action of estrogen-regulated cytokines in human bone cells and lay the foundations for the use of cytokine inhibitors in the treatment of postmenopausal osteoporosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Estrogen acts via suppression of bone resorption [43–45]”
From The Effect of Tobacco Smoking on Bone Mass: An Overview of Pathophysiologic Mechanisms (2018) · cites this paper as [44]
In the citing paper
“In addition, estrogen inhibits osteoclast formation by reducing the levels of other osteoclastogenic cytokines such as IL-1, IL-6, IL-11, TNF-α, TNF-β, and M-CSF [160, 161].”
From Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells (2015) · cites this paper as [160]
Citations
Cites
Interleukin-1 and interleukin-1 antagonism
Dinarello, C. (1991) · Blood · doi:10.1182/blood.v77.8.1627.1627 · Cited by 2,304
Yoshida, H., Hayashi, S.-I., Kunisada, T., Ogawa, M., Nishikawa, S., Okamura, H., Sudo, T., Shultz, L. D., & Nishikawa, S.-I. (1990) · Nature · doi:10.1038/345442a0 · Cited by 1,789
Increased Osteoclast Development After Estrogen Loss: Mediation by Interleukin-6
Jilka, R. L., Hangoc, G., Girasole, G., Passeri, G., Williams, D. C., Abrams, J. S., Boyce, B., Broxmeyer, H., & Manolagas, S. C. (1992) · Science · doi:10.1126/science.1621100 · Cited by 1,442
Bertolini, D. R., Nedwin, G. E., Bringman, T. S., Smith, D. D., & Mundy, G. R. (1986) · Nature · doi:10.1038/319516a0 · Cited by 1,434
Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo
Hughes, D. E., Wright, K. R., Uy, H. L., Sasaki, A., Yoneda, T., Roodman, D. G., Mundy, G. R., & Dr. Boyce, B. F. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650101008 · Cited by 1,040
An interleukin 1 like factor stimulates bone resorption in vitro
Gowen, M., Wood, D. D., Ihrie, E. J., McGuire, M. K. B., & Russell, R. G. G. (1983) · Nature · doi:10.1038/306378a0 · Cited by 1,012
Modulation of Osteoclast Differentiation
SUDA, T., TAKAHASHI, N., & MARTIN, T. J. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-1-66 · Cited by 1,004
Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6.
Tamura, T., Udagawa, N., Takahashi, N., Miyaura, C., Tanaka, S., Yamada, Y., Koishihara, Y., Ohsugi, Y., Kumaki, K., & Taga, T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11924 · Cited by 825
TURNER, R. T., RIGGS, B. L., & SPELSBERG, T. C. (1994) · Endocrine Reviews · doi:10.1210/edrv-15-3-275 · Cited by 754
Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion.
Poli, V., Balena, R., Fattori, E., Markatos, A., Yamamoto, M., Tanaka, H., Ciliberto, G., Rodan, G. A., & Costantini, F. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06368.x · Cited by 749
Repression of the Interleukin-6 Promoter by Estrogen Receptor Is Mediated by NF-κB and C/EBPβ
Stein, B., & Yang, M. X. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.9.4971 · Cited by 704
Girasole, G., Jilka, R. L., Passeri, G., Boswell, S., Boder, G., Williams, D. C., & Manolagas, S. C. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115668 · Cited by 679
Tanaka, S., Takahashi, N., Udagawa, N., Tamura, T., Akatsu, T., Stanley, E. R., Kurokawa, T., & Suda, T. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116179 · Cited by 577
Pacifici, R., Brown, C., Puscheck, E., Friedrich, E., Slatopolsky, E., Maggio, D., McCracken, R., & Avioli, L. V. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.12.5134 · Cited by 555
Self-citationThomson, B. M., Mundy, G. R., & Chambers, T. J. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.3.775 · Cited by 536
Pfeilschifter, J., Chenu, C., Bird, A., Mundy, G. R., & Roodman, D. G. (1989) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650040116 · Cited by 468
Cytokines and Estrogen in Bone: Anti-Osteoporotic Effects
Horowitz, M. C. (1993) · Science · doi:10.1126/science.8480174 · Cited by 453
Felix, R., Cecchini, M. G., & Fleisch, H. (1990) · Endocrinology · doi:10.1210/endo-127-5-2592 · Cited by 438
Udagawa, N., Takahashi, N., Katagiri, T., Tamura, T., Wada, S., Findlay, D. M., Martin, T. J., Hirota, H., Taga, T., Kishimoto, T., et al. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.5.1461 · Cited by 409
Osteoblasts mediate interleukin 1 stimulation of bone resorption by rat osteoclasts.
Thomson, B. M., Saklatvala, J., & Chambers, T. J. (1986) · The Journal of experimental medicine · doi:10.1084/jem.164.1.104 · Cited by 387
Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin 1 release.
Pacifici, R., Rifas, L., McCracken, R., Vered, I., McMurtry, C., Avioli, L. V., & Peck, W. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.7.2398 · Cited by 375
Self-citationLöwik, C. W. G. M., van der Pluijm, G., Bloys, H., Hoekman, K., Bijvoet, O. L. M., Aarden, L. A., & Papapoulos, S. E. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)90851-6 · Cited by 373
Effects of Interleukin-1 on Bone Turnover in Normal Mice*
BOYCE, B. F., AUFDEMORTE, T. B., GARRETT, I. R., YATES, A. J. P., & MUNDY, G. R. (1989) · Endocrinology · doi:10.1210/endo-125-3-1142 · Cited by 363
Kitazawa, R., Kimble, R. B., Vannice, J. L., Kung, V. T., & Pacifici, R. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117606 · Cited by 336
Self-citationThe biological properties of interleukin-1.
Dinarello, C. A. (1994) · PubMed · Cited by 317
Interleukin‐1: A possible role in the infertility associated with endometriosis
Fakih, H., Baggett, B., & Holtz, G. (1988) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(88)90224-x · Cited by 316
Pacifici, R., Rifas, L., Teitelbaum, S., Slatopolsky, E., McCracken, R., Bergfeld, M., Lee, W., Avioli, L. V., & Peck, W. A. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.13.4616 · Cited by 302
Self-citationRay, A., Prefontaine, K. E., & Ray, P. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99966-7 · Cited by 301
Interleukin-1: a possible role in the infertility associated with endometriosis
Fakih, H., Baggett, B., Holtz, G., Tsang, K.-Y., Lee, J. C., & Williamson, H. O. (1987) · Fertility and Sterility · doi:10.1016/s0015-0282(16)49993-0 · Cited by 286
Pottratz, S. T., Bellido, T., Mocharla, H., Crabb, D., & Manolagas, S. C. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117100 · Cited by 274
Kimble, R. B., Matayoshi, A. B., Vannice, J. L., Kung, V. T., Williams, C., & Pacifici, R. (1995) · Endocrinology · doi:10.1210/endo.136.7.7789332 · Cited by 273
Self-citationPerspectives: Interleukin-6: An osteotropic factor?
Roodman, G. D. (1992) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650070502 · Cited by 272
OURSLER, M. J., CORTESE, C., KEETING, P., ANDERSON, M. A., BONDE, S. K., RIGGS, B. L., & SPELSBERG, T. C. (1991) · Endocrinology · doi:10.1210/endo-129-6-3313 · Cited by 265
Interleukin-1β is a potent inhibitor of bone formation in vitro
Dr. Stashenko, P., Dewhirst, F. E., Rooney, M. L., Desjardins, L. A., & Heeley, J. D. (1987) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650020612 · Cited by 255
Turner, R. T. (1994) · Endocrine Reviews · doi:10.1210/er.15.3.275 · Cited by 242
Fibbe, W., van Damme, J., Billiau, A., Goselink, H., Voogt, P., van Eeden, G., Ralph, P., Altrock, B., & Falkenburg, J. (1988) · Blood · doi:10.1182/blood.v71.2.430.430 · Cited by 241
Elias, J. A., & Lentz, V (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.1.161 · Cited by 239
Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized rats.
Kimble, R. B., Vannice, J. L., Bloedow, D. C., Thompson, R. C., Hopfer, W., Kung, V. T., Brownfield, C., & Pacifici, R. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117187 · Cited by 233
Self-citationRalston, S. H., Russell, R. G. G., & Gowen, M. (1990) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650050912 · Cited by 231
KURIHARA, N., CHENU, C., MILLER, M., CIVIN, C., & ROODMAN, G. D. (1990) · Endocrinology · doi:10.1210/endo-126-5-2733 · Cited by 227
Symons, J. A., Young, P. R., & Duff, G. W. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.5.1714 · Cited by 227
MacDonald, B. R., Mundy, G. R., Clark, S., Wang, E. A., Kuehl, T. J., Stanley, E. R., & Roodman, G. D. (1986) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650010210 · Cited by 217
Infusions of recombinant human interleukins 1 alpha and 1 beta cause hypercalcemia in normal mice.
Sabatini, M., Boyce, B., Aufdemorte, T., Bonewald, L., & Mundy, G. R. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5235 · Cited by 216
Generation of osteoclasts from isolated hematopoietic progenitor cells
Kurihara, N., Suda, T., Miura, Y., Nakauchi, H., Kodama, H., Hiura, K., Hakeda, Y., & Kumegawa, M. (1989) · Blood · doi:10.1182/blood.v74.4.1295.1295 · Cited by 202
Increased interleukin-6 production by murine bone marrow and bone cells after estrogen withdrawal
Passeri, G. (1993) · Endocrinology · doi:10.1210/en.133.2.822 · Cited by 186
Role of colony-stimulating factors in osteoclast development
Takahashi, N., Udagawa, N., Akatsu, T., Tanaka, H., Shionome, M., & Dr. Suda, T. (1991) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650060912 · Cited by 178
Oestrogen Receptors in Macrophages
GULSHAN, S., McCRUDEN, A. B., & STIMSON, W. H. (1990) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1990.tb02820.x · Cited by 177
CANALIS, E. (1986) · Endocrinology · doi:10.1210/endo-118-1-74 · Cited by 176
Ralston, S. H. (1994) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650090614 · Cited by 174
Gowen, M., Wood, D. D., & Russell, R. G. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111819 · Cited by 173
Interleukin-1 beta stimulates bone resorption and inhibits bone formation in vivo.
Nguyen, L., Dewhirst, F. E., Hauschka, P. V., & Stashenko, P. (1991) · PubMed · Cited by 163
POLAN, M. L., LOUKIDES, J., NELSON, P., CARDING, S., DIAMOND, M., WALSH, A., & BOTTOMLY, K. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-69-6-1200 · Cited by 163
Chaudhary, L. R. (1992) · Endocrinology · doi:10.1210/en.130.5.2528 · Cited by 162
Endogenous bone-resorbing factors in estrogen deficiency: Cooperative effects of IL-1 and IL-6
Miyaura, C., Kusano, K., Masuzawa, T., Chaki, O., Onoe, Y., Aoyagi, M., Sasaki, T., Tamura, T., Koishihara, Y., Ohsugi, Y., et al. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650100914 · Cited by 160
Burger, D., Chicheportiche, R., Giri, J. G., & Dayer, J. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118045 · Cited by 159
Johnson, R., Boyce, B. F., Mundy, G. R., & Roodman, G. D. (1989) · Endocrinology · doi:10.1210/endo-124-3-1424 · Cited by 152
Bismar, H. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.11.3351 · Cited by 144
PACIFICI, R., ROTHSTEIN, M., RIFAS, L., LAU, K.-H. W., BAYLINK, D. J., AVIOLI, L. V., & HRUSKA, K. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-1-138 · Cited by 140
Self-citationLORENZO, J. A., SOUSA, S. L., ALANDER, C., RAISZ, L. G., & DINARELLO, C. A. (1987) · Endocrinology · doi:10.1210/endo-121-3-1164 · Cited by 134
Cohen-Solal, M. E. (1993) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.77.6.1648 · Cited by 131
Kurihara, N., Civin, C., & Roodman, G. D. (1991) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650060307 · Cited by 115
Presence of oestrogen receptors in human blood mononuclear cells and thymocytes
Weusten, J. J. A. M., Blankenstein, M. A., Gmelig-Meyling, F. H. J., Schuurman, H. J., Kater, L., & Thijssen, J. H. H. (1986) · Acta Endocrinologica · doi:10.1530/acta.0.1120409 · Cited by 115
Rifas, L. (1995) · Endocrinology · doi:10.1210/en.136.9.4056 · Cited by 102
Self-citationPacifici, R. (1993) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.77.5.1135 · Cited by 101
Self-citationCirculating cytokine levels in osteoporotic and normal women
Khosla, S. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.79.3.707 · Cited by 99
Skeletal effects of withdrawal of estrogen and diphosphonate treatment in ovariectomized rats
Wronski, T. J., Dann, L. M., Qi, H., & Yen, C. ‐. (1993) · Calcified Tissue International · doi:10.1007/bf01321840 · Cited by 98
Elevated Plasma Levels of Interleukin‐6 in Postmenopausal Women Do Not Correlate with Bone Density
Kania, D. M., Binkley, N., Checovich, M., Havighurst, T., Schilling, M., & Ershler, W. B. (1995) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1995.tb07328.x · Cited by 97
Felix, R., Fleisch, H. A., & Elford, P. R. (1989) · Calcified Tissue International · doi:10.1007/bf02556317 · Cited by 95
Lorenzo, J., Sousa, S., Fonseca, J., Hock, J. M., & Medlock, E. S. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113042 · Cited by 91
Routtenberg, A. (1995) · Nature · doi:10.1038/374314b0 · Cited by 86
Bone matrix constituents stimulate interleukin-1 release from human blood mononuclear cells.
Pacifici, R., Carano, A., Santoro, S. A., Rifas, L., Jeffrey, J. J., Malone, J. D., McCracken, R., & Avioli, L. V. (1991) · Journal of Clinical Investigation · doi:10.1172/jci114975 · Cited by 84
Self-citationCutolo, M., Accardo, S., Villaggio, B., Clerico, P., Bagnasco, M., Coviello, D. A., Carruba, G., Casto, M. L., & Castagnetta, L. (1993) · Arthritis & Rheumatism · doi:10.1002/art.1780360809 · Cited by 84
Rickard, D. J., Russell, R. G. G., & Gowen, M. (1992) · Osteoporosis International · doi:10.1007/bf01623843 · Cited by 83
Human anti-interleukin 1α antibodies
Hansen, M. B., Svenson, M., & Bendtzen, K. (1991) · Immunology Letters · doi:10.1016/0165-2478(91)90102-g · Cited by 70
Macrophage heterogeneity occurs through a developmental mechanism.
Witsell, A. L., & Schook, L. B. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.5.1963 · Cited by 64
Pacifici, R., Basilico, C., Roman, J., Zutter, M. M., Santoro, S. A., & McCracken, R. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115586 · Cited by 62
Self-citationLong-Term Consequences of Interleukin-6 Overexpression in Transgenic Mice
WOODROOFE, C., MÜLLER, W., & RÜTHER, U. (1992) · DNA and Cell Biology · doi:10.1089/dna.1992.11.587 · Cited by 61
A soluble binding protein specific for interleukin 1β is produced by activated mononuclear cells
Symons, J. A., Eastgate, J. A., & Duff, G. W. (1990) · Cytokine · doi:10.1016/1043-4666(90)90015-l · Cited by 53
Hustmyer, F. G., Walker, E., Yu, X.-P., Girasole, G., Sakagami, Y., Peacock, M., & Manolagas, S. C. (1993) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650080108 · Cited by 52
Bone disease in rheumatoid arthritis
Sambrook, P. N., & REEVE, J. (1988) · Clinical Science · doi:10.1042/cs0740225 · Cited by 50
Reduced Bone Mass in Reproductive-Aged Women with Endometriosis*
Comite, F., DELMAN, M., Hutchinson-Williams, K. A., DeCherney, A. H., & Jensen, P. S. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-69-4-837 · Cited by 47
Pioli, G., Basini, G., Pedrazzoni, M., Musetti, G., Ulietti, V., Bresciani, D., Villa, P., Bacchi, A., Hughe, D., Russell, G., et al. (1992) · Clinical Science · doi:10.1042/cs0830503 · Cited by 42
Cytokine production by peripheral blood cells in postmenopausal osteoporosis
Zarrabeitia, M. T., Riancho, J. A., Amado, J., Napal, J. J., & González-Macı́as, J. (1991) · Bone and Mineral · doi:10.1016/0169-6009(91)90093-f · Cited by 39
Kimble, R. B., Kitazawa, R., Vannice, J. L., & Pacifici, R. (1994) · Calcified Tissue International · doi:10.1007/bf00310403 · Cited by 37
Self-citationCohen-Solal, M. E., Graulet, A. M., Guéris, J., Denne, M. A., Bergot, C., Morieux, C., Sedel, L., Kuntz, D., & de Vernejoul, M. C. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650100219 · Cited by 29
Fiore, C. E., Falcidia, E., Foti, R., Motta, M., & Tamburino, C. (1993) · Bone and Mineral · doi:10.1016/s0169-6009(08)80039-6 · Cited by 26
Interleukin abnormalities in recently active rheumatoid arthritis.
Tan, P., Shore, A., Leary, P., & Keystone, E. C. (1984) · PubMed · Cited by 26
Spontaneous release of interleukin-1 (IL-1) from medullary mononuclear cells of pagetic subjects
Pioli, G., Girasole, G., Pedrazzoni, M., Sansoni, P., Erroi, A., Davoli, L., Ciotti, G., Mantovani, A., & Passeri, M. (1989) · Calcified Tissue International · doi:10.1007/bf02556047 · Cited by 23
Matsuda, T., Matsui, K., Shimakoshi, Y., Aida, Y., & Hukuda, S. (1991) · Calcified Tissue International · doi:10.1007/bf02555851 · Cited by 19
Pluripotent hemopoietic stem cells give rise to osteoclasts in vitro: effects of rGM-CSF
Schneider, G., & Relfson, M. (1989) · Bone and Mineral · doi:10.1016/0169-6009(89)90091-3 · Cited by 14
Research works printed but not linked: 11
- Srivastava, 1995, Estrogen down-regulates the expression of M-CSF mRNA in bone marrow stromal cells by stimulating the production of the transcription factor EGR-1, J Bone Miner Res, 10, S18
- Matayoshi, 1995, Generation of human osteoclasts from peripheral blood cd 34+ cells, J Bone Miner Res, 10
- Pacifici, 1990, TNFα and GM-CSF secretion from human blood monocytes: Effect of menopause and estrogen replacement, J Bone Miner Res, 5, 145
- Kimble, 1996, Estrogen inhibits IL-1 and TNF gene expression in transfected murine macrophagic cells, J Bone Miner Res, 11
- Kaneki, 1991, The effect of menopause on IL-1 and IL-6 release from peripheral blood monocytes, J Bone Miner Res, 6, 76
- Thompson, 1991, IL-lra: Properties and uses of an interleukin-1 receptor antagonist, Agents Actions, 41
- Girasole, 1995, Increased serum soluble interleukin-6 receptor levels are induced by ovariectomy, prevented by estrogen replacement, and reversed by alendronate administration, J Bone Miner Res, 10, A86
- McKane, 1993, Effect of age and menopause on serum interleukin-1β and intereleukin-6- levels in women, J Bone Miner Res, 8, 162A
- Kimble, 1994, Long-term treatment with IL-1 receptor antagonist (IL-lra) blocks bone loss in ovariectomized rats, J Bone Miner Res, 9, B380
- Kimble, 1995, Inhibition of IL-6 activity is genetically normal mice does not prevent ovariectomy-induced bone loss, J Bone Miner Res, 10, s160
- Ammann, 1995, Transgenic mice expressing high levels of soluble tumor necrosis factor receptor-1 fusion protein are protected from bone loss caused by estrogen deficiency, J Bone Miner Res, 10
Cited by
Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification.
Bucay, N., Sarosi, I., Dunstan, C. R., Morony, S., Tarpley, J., Capparelli, C., Scully, S., Tan, H. L., Xu, W., Lacey, D. L., et al. (1998) · Genes & Development · doi:10.1101/gad.12.9.1260 · Cited by 2,483
Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells
Florencio-Silva, R., Sasso, G. R. D. S., Sasso-Cerri, E., Simões, M. J., & Cerri, P. S. (2015) · BioMed Research International · doi:10.1155/2015/421746 · Cited by 2,044
Sex Steroids and the Construction and Conservation of the Adult Skeleton
Riggs, B. L., Khosla, S., & Melton, L. J. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.3.0465 · Cited by 1,846
Sambrook, P., & Cooper, C. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68891-0 · Cited by 1,165
Hofbauer, L. C., Khosla, S., Dunstan, C. R., Lacey, D. L., Boyle, W. J., & Riggs, B. L. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.1.2 · Cited by 1,173
Metadata
- Authors
- Pacifici, R.
- Affiliations
- Washington University in St. Louis (US)
- Corresponding author
- Pacifici, Roberto
- ORCID
- Pacifici, Roberto
- Venue
- Journal of Bone and Mineral Research
- Publisher
- Oxford University Press (OUP)
- Published
- 1996-08-01
- Volume
- 11
- Issue
- 8
- Pages
- 1043-1051
- ISSN
- 0884-0431 (ISSN-L)
- 1523-4681
- OpenAlex
- W2110993073
- Cited by
- 741
- References
- 90
- Citations by year
- 2026: 11 · 2025: 13 · 2024: 15 · 2023: 20 · 2022: 20 · 2021: 24 · 2020: 20 · 2019: 26 · 2018: 30 · 2017: 15 · 2016: 19 · 2015: 31 · 2014: 29 · 2013: 22 · 2012: 28
- FWCI
- 2.44
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Journal of Bone and Mineral Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ag013534-04)
- National Institute on Aging (AG 13534)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR041412, AR41412)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- postmenopausal osteoporosis, estrogen deficiency, cytokines, interleukin-1, TNF-α, bone resorption, osteoclastogenesis, osteoclast apoptosis, bone marrow, cytokine synergy, estrogen withdrawal, cytokine inhibitors
- MeSH terms
- Animals, Bone and Bones, Bone Resorption, Estrogens, Female, Humans, Menopause, Osteoporosis, Postmenopausal, Estrogen Replacement Therapy, Cytokines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.